Senna S Tablet
NDC Package 21130-883-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Senna S (docusate sodium, sennosides) tablets is a medication used to treat constipation. This formulation utilizes a tablet delivery system. Marketed by Safeway, Inc., this product is identified by NDC 21130-883 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
21130-883-30
Package Description
1 BOTTLE, PLASTIC in 1 BOX / 30 TABLET in 1 BOTTLE, PLASTIC
Product Code
21130-883
11-Digit Billing Format
21130088330
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Senna S
Non-Proprietary Name
Docusate Sodium, Sennosides
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
This product is used to treat constipation. It contains 2 medications: sennosides and docusate. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which helps to cause movement of the intestines. Docusate is known as a stool softener. It helps increase the amount of water in the stool, making it softer and easier to pass.

Regulatory & Marketing

Labeler Name
Safeway, Inc.
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-29-2019
End Marketing Date
12-29-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21130-883-30 identifies a specific commercial package of 1 bottle, plastic in 1 box / 30 tablet in 1 bottle, plastic of Senna S, a human over the counter drug labeled by Safeway, Inc.. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Safeway, Inc. on November 29, 2019.

What are the primary indications for this medication?

This product is used to treat constipation. It contains 2 medications: sennosides and docusate. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which helps to cause movement of the intestines. Docusate is known as a stool softener. It helps increase the amount of water in the stool, making it softer and easier to pass.

How is this Safeway, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21130088330. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21130-883-30
11-Digit CMS (5-4-2)
21130-0883-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.